02:49 PM EDT, 08/13/2026 (MT Newswires) -- Abeona Therapeutics ( ABEO ) shares were down nearly 15% in afternoon trading on Thursday after Q2 results missed analysts' expectations.

The company reported a Q2 net loss of $0.35 per diluted share, swinging from earnings of $1.71 a year earlier.

Analysts polled by FactSet expected a loss of $0.23.

Revenue for the quarter ended June 30 was $11.4 million, up from $400,000 a year earlier.

Analysts expected revenue of $12.2 million.

As of June 30, the company said it had $146.8 million in cash and or cash equivalents on hand.

Price: 6.36, Change: -1.11, Percent Change: -14.81